Are individuals that took Actos, ActoPlus Met, ActoPlus Met XR or Duetact in danger of bladder cancer? Patients that have taken these drugs and which have been diagnosed with bladder cancer may have a legal claim for compensation. The FDA made a safety announcement concerned Actos and bladder cancer. Patients taking pioglitazone for more than a year may have an increased risk of developing cancerous tumors of the bladder. Pioglitazone is found in these diabetes drugs. People have alleged that the drug maker Takeda Pharmaceutical did not disclose information about the Actos bladder cancer risk. According to at least one source, it is claimed that there were allegations the Takeda failed to provide adequate warnings with its diabetes drug.
People diagnosed with bladder cancer after taking Actos, ActoPlus Met, ActoPlus Met XR or Duetact may be entitled to financial compensation. Feel free to contact this law firm to determine if you are eligible to make a claim. Do you have a family member that took Actos and dies of bladder cancer? Do you have questions about wrongful death claims?
You may have questions about the link between Actos and bladder cancer. Note that on June 15, 2011, the FDA released a safety announcement concerning Actos and bladder cancer. The FDA released the Actos bladder cancer warning after reviewing information from a five-year analysis of a drug study. Due to the link between Actos and bladder cancer, the FDA has advised that pioglitazone should not be prescribed to individuals who have bladder cancer.
If you are an Actos user, be on alert for the signs described below and consult your doctor for proper analysis. Signs which may possibly indicate Actos bladder cancer are: (1) Blood in urine; (2) Back or lower abdominal pain; (3) Urgent need to urinate; and (4) Pain during urination.
– Article By Richard Weaver